US FDA approves new treatment for HER2-positive breast cancer

被引：0
|
作者：
Galukande, Natasha
机构：
来源：
PHARMACOGENOMICS | 2013年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：600 / 600
页数：1
相关论文
共 50 条
  • [1] New developments in the treatment of HER2-positive breast cancer
    Nahta, Rita
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 53 - 64
  • [2] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    BREAST, 2014, 23 (02): : 128 - 136
  • [3] New Treatment Option for advanced HER2-positive Breast Cancer
    Forstmeyer, D.
    ONKOLOGE, 2013, 19 (01): : 60 - 61
  • [4] A new era for treatment development in HER2-positive breast cancer
    Pivot, Xavier
    Cox, David G.
    LANCET ONCOLOGY, 2018, 19 (02): : 160 - 162
  • [5] FDA approves new breast cancer treatment
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (23) : 2406 - 2406
  • [6] Treatment of HER2-Positive Metastatic Breast Cancer
    van Ramshorst, Mette S.
    Sonke, Gabe S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20): : 1964 - 1964
  • [7] Progression and treatment of HER2-positive breast cancer
    April Davoli
    Barbara A. Hocevar
    Thomas L. Brown
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 611 - 623
  • [8] Optimizing Treatment of HER2-Positive Breast Cancer
    Gradishar, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 649 - 651
  • [9] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [10] Treatment strategy for HER2-positive breast cancer
    Mukai, Hirofumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 335 - 340
12345